index: hide

#### ALK Rearrangement Positive
- First-line therapy
  - Alectinib {gen.nscl.principles.i.'8},{gen.nscl.principles.i.'9}
  - Brigatinib {gen.nscl.principles.i.'10}
  - Ceritinib {gen.nscl.principles.i.'11}
  - Crizotinib {gen.nscl.principles.i.'8},{gen.nscl.principles.i.'12}
- Subsequent therapy
  - Alectinib {gen.nscl.principles.i.'13},{gen.nscl.principles.i.'14}
  - Brigatinib {gen.nscl.principles.i.'15}
  - Ceritinib {gen.nscl.principles.i.'16}
  - Lorlatinib {gen.nscl.principles.i.'17}
